The latest closing stock price for Cyclerion Therapeutics as of January 31, 2025 is 3.92.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-986 today, roughly -1 times their original investment - a -51.19% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 369.20 on April 10, 2019.
The Cyclerion Therapeutics 52-week high stock price is 9.47, which is 141.6% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.27, which is 67.6% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.90.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-986 today, roughly -1 times their original investment - a -51.19% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 369.20 on April 10, 2019.
The Cyclerion Therapeutics 52-week high stock price is 9.47, which is 141.6% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.27, which is 67.6% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.90.